Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With or Without Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Patients With Clinically Confined Prostate Adenocarcinoma

NCT02339948 is registered in ClinicalTrials.gov with GenesisCare USA as lead sponsor.

NCT NCT02339948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02339948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With or Without Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Patients With Clinically Confined Prostate Adenocarcinoma
Lead sponsor
GenesisCare USA
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2006
Completion date
October 31, 2019
Enrollment
279 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma